Abbott Laboratories
XHAM:ABL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abbott Laboratories
XHAM:ABL
|
US |
Intrinsic Value
The intrinsic value of 
Abbott Laboratories (ABL) under the Base Case is 96.22 EUR per share.
Compared with the current market price of 96.74 EUR, the stock appears
Overvalued by 1% .
The intrinsic value is the average of valuations using the DCF method and multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Abbott Laboratories Does
Abbott Laboratories is a healthcare company that makes products doctors, hospitals, and patients use every day. Its business is built around four main areas: medical devices, diagnostic tests, nutrition products, and established medicines in international markets. In simple terms, Abbott sells tools to monitor health, tests to find disease, food and nutrition products for infants and adults, and selected brand-name medicines outside the United States.
- Headquarters
- United States of America US
- Employees
- 115 000
- IPO date
- Mar 1, 1937
Abbott Laboratories has a narrow economic moat
Patents and medical approvals make Abbott’s protected devices difficult to copy and bring to market. Laboratories that build their testing around Abbott equipment also face work and disruption when changing suppliers, helping Abbott retain repeat purchases. These protections are strongest in particular products rather than across everything Abbott sells.
Read the full moat analysis
Revenue & Expenses Breakdown
Abbott Laboratories
Earnings Waterfall
Abbott Laboratories
The intrinsic value for Abbott Laboratories (ABL) under the Base Case is 96.22 EUR.
Compared with the current market price of 96.74 EUR, the stock appears Overvalued by 1% .